For the best user experience please use a browser to proceed.

CGIX - Cancer Genetics, Inc price and analysis

Fundamentals:
Basic Info:
  • Market Cap:
  • Exchange:
  • Shares Float:
  • Shares Outstanding:
  • Revenue Per Employee:
Advanced Info:
  • ROE ttm:
  • ROA ttm:
  • Beta:
  • EPS:
  • Debt Ratio ttm:
  • Debt / Equity Ratio ttm:
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm:
  • Current Ratio ttm:
  • Quick Ratio ttm:
Key Ratios:
  • P/E trailing 12 month:
  • P/E forward:
  • P/E trailing 12m high:
  • P/E trailing 12m low:
  • P/S trailing 12 month:
  • EV/S trailing 12 month:
  • P/B trailing 12 month:
  • PEG ratio:
Shorts:
  • Shares Short:
  • Shares Short Prev Month:
  • Days to Cover:
  • Short Percent Float:
  • Short Percent Outstanding:
Ownership:
  • Percent Insiders:
  • Percent Institutions:
Margins:
  • Gross Profit Margin ttm:
  • EBITDA Margin ttm:
  • Operating Margin ttm:
  • Net Income Margin ttm:
Target Prices:
  • Target Price High:
  • Target Price Low:
  • Target Price Mean:
  • Number of Analysts:
Key Prices:
  • 52 Week High:
  • 52 Week Low:
  • 50 Day Moving Average:
  • 200 Day Moving Average:
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date:
Current Quarter Estimates:
  • Current Quarter EPS estimate: 0 ~ 0 (2019-03-31)
  • Current Quarter revenue estimate: 10.77M ~ 10.77M
  • Median revenue growth YoY estimate: 40.47%
Latest News:
Vyant Bio Announces Newly Appointed Board of DirectorsGlobeNewswire2021-04-05 20:20:00 EDT
Cancer Genetics (CGIX) and StemoniX Announce Merger ClosingStreetInsider.com2021-03-31 10:37:27 EDT
Cancer Genetics and StemoniX Announce Merger ClosingYahoo Finance2021-03-31 10:30:00 EDT
Why AzurRx BioPharma, Usana Health Are Moving TodayBenzinga2021-02-10 11:47:07 EDT
Cancer Genetics, Inc. (CGIX)YAHOO!2021-02-10 00:01:00 EDT
Cancer Genetics Inc.Barron's2021-01-21 10:04:00 EDT
Standard AVB Financial Corp. (STND)Finance Yahoo2020-12-01 00:01:00 EDT
Cancer Genetics: 3Q Earnings SnapshotAssociated Press2020-11-12 21:45:00 EDT
VARIAN MEDICAL SYS DL 1 (VNM.MU)YAHOO!2020-10-16 05:48:00 EDT
Daily Insider Ratings Round Up - Feb. 1, 2019Seeking Alpha2019-02-04 00:00:00 EDT
Daily Insider Ratings Round Up 1/16/19Seeking Alpha2019-01-18 00:00:00 EDT
Click to expand the area.
Income Statements:
CGIX - Cancer Genetics, Inc Income Statement
Unit: (thousand)2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q3
Qtr Revenue7523.007667.007036.005940.006827.006839.001525.002069.001889.001426.001446.001568.00
Rev Growth yoy4.05 %10.06 %6.54 %-26.01 %-9.25 %-10.80 %-78.33 %-65.17 %-72.33 %-79.15 %-5.18 %-24.21 %
Cost of Revenue5239.005082.004853.004654.004135.004637.00725.00960.001070.00814.00640.00912.00
Gross Profit2284.002585.002183.001286.002692.002202.00800.001109.00819.00612.00806.00656.00
Gross Profit Mgn30.36 %33.72 %31.03 %21.65 %39.43 %32.2 %52.46 %53.6 %43.36 %42.92 %55.74 %41.84 %
Research and Development1709.00681.00673.00692.00442.00454.007.0000000
Selling & Marketing Expense1553.001591.001341.001280.001056.001108.00322.00322.00321.00341.00284.00354.00
General & Administrative Expense10095.006851.006760.006284.005290.004417.001588.001612.001029.001874.002516.001571.00
Interest Expense1331.00239.00578.00465.00838.001725.00514.00200.00110.0078.0097.00108.00
Operating Expense11804.007532.007433.006976.005732.004871.001595.001612.001029.001874.002516.001571.00
Operating Income-9520.00-4947.00-5250.00-5690.00-3040.00-2669.00-795.00-503.00-210.00-1262.00-1710.00-915.00
Operating Mgn-126.55 %-64.52 %-74.62 %-95.79 %-44.53 %-39.03 %-52.13 %-24.31 %-11.12 %-88.5 %-118.26 %-58.35 %
Net Income-7901.00-4456.00-3633.00-8519.00-3765.00-4617.00-3773.001975.00-293.00-1179.00-1700.00-1353.00
Net Income Mgn-105.02 %-58.12 %-51.63 %-143.42 %-55.15 %-67.51 %-247.41 %95.46 %-15.51 %-82.68 %-117.57 %-86.29 %
Generated by @earningsfly with ❤️
Cashflow Statements:
CGIX - Cancer Genetics, Inc Cashflow Statement
Unit: (million)2017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q3
Operating Cashflows-3.31-4.47-3.63-3.30-1.15-4.46-0.40-0.68-3.12-0.16-1.74-1.67
Financing Cashflows8.66-0.71-0.153.21-0.215.110.35-0.26-1.89-0.16-0.16-0.09
Investing Cashflows-0.63-0.251.21-0.240.36-0.03-0.022.516.640.030.900.04
Total Capital Expenditures0.090.220.310.270.150.030.010.050.0300.040
Changes In Cash4.73-5.44-3.43-0.32-1.000.61-3.731.571.62-0.30-1.77-1.73
Free Cash flow-3.46-4.72-3.97-3.58-0.96-4.50-0.38-0.73-3.08-0.16-1.78-1.67
Generated by @earningsfly with love ❤️
Balance Sheets:
CGIX - Cancer Genetics, Inc Balance Sheet
Unit: (thousand)2018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q4
Total Assets46444.0041371.0039885.0035406.001047.001017.002497.0014904.0014282.0011788.009690.008348.00
Intangible Assets21632.0021533.0021378.009312.0021174.009089.006111.005985.005906.005771.005653.002977.00
Goodwill17257.0017257.0017257.005963.0017257.005963.003090.003090.003090.003090.003090.002977.00
Current Assets19037.0014203.0013115.0024455.00697.00667.002147.007178.006866.004622.002801.004107.00
Current Cash4022.001601.001206.00161.00697.00667.002147.003880.003593.002864.001133.002400.00
Account Receivables10335.009357.008981.007038.007292.00691.001506.001443.002508.001351.00914.00870.00
Inventory0.000.000.001438.000.000.000.000.000.000.000.000.00
Total Liabilities26390.0024091.0030637.0028604.0030813.0032175.0013372.007519.007902.006687.004885.004368.00
Account Payables0.000.000.000.000.000.000.000.000.000.000.000.00
Short Term Debt9510.009438.0011066.002481.008778.003101.002273.001277.001313.00840.0038.00223.00
Long Term Debt9510.009438.0011066.002481.0011192.003101.002273.001277.001313.00840.000.000.00
Current Ratio0.920.660.460.870.020.020.171.030.900.710.590.96
Debt Ratio0.410.460.550.1419.076.101.820.170.180.140.000.03
Debt/Equity Ratio0.951.092.390.732.601.260.610.350.410.330.01Infinity
Generated by @earningsfly with ❤️
Latest Posts:
Not available at this time..
Cancer Genetics, Inc
Cancer Genetics, Inc

Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. The company's clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybr...
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 110
Keywords: cancer genetics
Summary and stock analysis:
  • Return on equity score:
  • Return on assets score:
737 Followers
304 Followers
Avg: 
 40 review, 26 jobs
Basic Info:
  • Market Cap:
  • Exchange:
  • Shares Float:
  • Shares Outstanding:
  • Revenue Per Employee:
Advanced Info:
  • ROE ttm:
  • ROA ttm:
  • Beta:
  • EPS:
  • Debt Ratio ttm:
  • Debt / Equity Ratio ttm:
  • Payout Ratio ttm:
Cash Ratios:
  • Cash Ratio ttm:
  • Current Ratio ttm:
  • Quick Ratio ttm:
Key Ratios:
  • P/E trailing 12 month:
  • P/E forward:
  • P/E trailing 12m high:
  • P/E trailing 12m low:
  • P/S trailing 12 month:
  • EV/S trailing 12 month:
  • P/B trailing 12 month:
  • PEG ratio:
Shorts:
  • Shares Short:
  • Shares Short Prev Month:
  • Days to Cover:
  • Short Percent Float:
  • Short Percent Outstanding:
Ownership:
  • Percent Insiders:
  • Percent Institutions:
Margins:
  • Gross Profit Margin ttm:
  • EBITDA Margin ttm:
  • Operating Margin ttm:
  • Net Income Margin ttm:
Target Prices:
  • Target Price High:
  • Target Price Low:
  • Target Price Mean:
  • Number of Analysts:
Key Prices:
  • 52 Week High:
  • 52 Week Low:
  • 50 Day Moving Average:
  • 200 Day Moving Average:
Dividends:
  • Trailing Dividend yld:
  • Forward Dividend yld:
  • Payout Ratio:
  • Ex-Dividend date:
Current Quarter Estimates:
  • Current Quarter EPS estimate: 0 ~ 0 (2019-03-31)
  • Current Quarter revenue estimate: 10.77M ~ 10.77M
  • Median revenue growth YoY estimate: 40.47%
Click to expand the area.
Analyst Consensus:
CGIX - Cancer Genetics, Inc Analyst Opinions

Generated by @earningsfly with ❤️
Analyst Trends:
CGIX - Cancer Genetics, Inc Analyst Trends
Generated by @earningsfly with ❤️
Website Ranking Analysis:
CGIX - Cancer Genetics, Inc  World Website Ranking Analysis
Generated by @earningsfly with ❤️
Google Trends Analysis:
CGIX - Cancer Genetics, Inc Google 5-year Trends Analysis
Generated by @earningsfly with ❤️
Employees Analysis:
CGIX - Cancer Genetics, Inc Employees Analysis
Generated by @earningsfly with ❤️
Institution & Insiders Analysis:
CGIX - Cancer Genetics, Inc Ownership Analysis
Generated by @earningsfly with ❤️
Debt & Cash Analysis:
CGIX - Cancer Genetics, Inc Cash and Debt Analysis(unit: thousands USD)
Generated by @earningsfly with ❤️
Short Analysis:
CGIX - Cancer Genetics, Inc Shorts Analysis
Generated by @earningsfly with 🚀
Margins and Revenue:
CGIX - Cancer Genetics, Inc Revenue and Margins
Generated by @earningsfly with 🚀
Income Statement Analysis:
CGIX - Cancer Genetics, Inc Income Statement
Unit: (thousand)2019Q42020Q12020Q22020Q3
Qtr Revenue1889.001426.001446.001568.00
Rev Growth yoy-72.33 %-79.15 %-5.18 %-24.21 %
Cost of Revenue1070.00814.00640.00912.00
Gross Profit819.00612.00806.00656.00
Gross Profit Mgn43.36 %42.92 %55.74 %41.84 %
Research and Development0000
Selling & Marketing Expense321.00341.00284.00354.00
General & Administrative Expense1029.001874.002516.001571.00
Interest Expense110.0078.0097.00108.00
Operating Expense1029.001874.002516.001571.00
Operating Income-210.00-1262.00-1710.00-915.00
Operating Mgn-11.12 %-88.5 %-118.26 %-58.35 %
Net Income-293.00-1179.00-1700.00-1353.00
Net Income Mgn-15.51 %-82.68 %-117.57 %-86.29 %
Generated by @earningsfly with ❤️
Earnings Estimate Analysis:
CGIX - Cancer Genetics, Inc EPS Estimates
Generated by @earningsfly with ❤️
Cashflow Analysis:
CGIX - Cancer Genetics, Inc Cashflow Statement
Unit: (million)2019Q42020Q12020Q22020Q3
Operating Cashflows-3.12-0.16-1.74-1.67
Financing Cashflows-1.89-0.16-0.16-0.09
Investing Cashflows6.640.030.900.04
Total Capital Expenditures0.0300.040
Changes In Cash1.62-0.30-1.77-1.73
Free Cash flow-3.08-0.16-1.78-1.67
Generated by @earningsfly with love ❤️